Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry Ученые записки Крымского федерального университета имени В.И. Вернадского. Биология. Химия. 2413-1725 91817 10.29039/2413-1725-2024-10-3-106-127 БИОЛОГИЧЕСКИЕ НАУКИ BIOLOGICAL SCIENCES БИОЛОГИЧЕСКИЕ НАУКИ OXIDATIVE STRESS AS A MOLECULAR BASIS FOR NEURODEGENERATIVE DISEASES AND ANTIOXIDANT THERAPY PATHWAYS ОКИСЛИТЕЛЬНЫЙ СТРЕСС КАК МОЛЕКУЛЯРНАЯ ОСНОВА НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ И ПУТИ АНТИОКСИДАНТНОЙ ТЕРАПИИ Микашинович З. И. Mikashinovich Z. I. Телесманич Н. Р. Telesmanich N. R. Смирнова О. Б. Smirnova O. B. Ростовский государственный медицинский университет Rostov State Medical University 12 12 2024 12 12 2024 10 3 106 127 11 12 2024 https://sn-biolchem.cfuv.ru/okislitelnyj-stress-kak-molekulyarnaya-osnova-nejrodegenerativnyh-zabolevanij-i-puti-antioksidantnoj-terapii/

В обзоре представлены результаты клинических и экспериментальных исследований, демонстрирующие патогенетическую роль окислительного стресса в генезе нейродегенеративных заболеваний (НДЗ). Различные по этиологии и клинической симптоматике заболевания нервной системы имеют общие механизмы, связанные с повреждением биомолекул: неправильной укладкой белков, их агрегацией, нарушением про- и антиоксидантного баланса. Усиление образования активных форм кислорода (АФК) индуцирует митоптоз, апоптоз, ферроптоз – факторов, приводящих к нарушению функциональной активности структурных единиц нейрона как главного элемента нервной системы. Несмотря на то, что однозначного признания эффективности антиоксидантной терапии в настоящее время нет, тем не менее, применение антиоксидантов можно рассматривать как важнейшее звено нейропротекции, имеющей патогенетическое обоснование

The review presents the results of clinical and experimental studies demonstrating the pathogenetic role of oxidative stress in the genesis of neurodegenerative diseases (NDD), obtained using a complex of clinical, laboratory and instrumental methods that reveal the role of oxidative stress and antioxidants in NDD. In the process of preparing the materials, sources from international and domestic databases were used: Scopus, Web of Science, Pub Medline, RSCI, mainly over the past 15 years (2010–2024). Diseases of the nervous system that differ in etiology and clinical symptoms have common mechanisms associated with damage to biomolecules: improper protein stacking, their aggregation, and violation of the pro- and antioxidant balance. Increased formation of reactive oxygen species (ROS) induces mitoptosis, apoptosis, and ferroptosis, factors that lead to impaired functional activity of neuron structural units as the main element of the nervous system. Given the complexity of the pathogenesis of NDZ, a promising methodological approach is to calculate the leading factors of pathogenesis. Undoubtedly, this makes it possible to standardize diagnosis and therapy, and subsequently create clinical recommendations. The purpose of this work was to analyze the role of participants in oxidative stress in key stages of the inflammatory process underlying NDZ. Despite the fact that there is currently no unambiguous recognition of the effectiveness of antioxidant therapy, nevertheless, the use of antioxidants can be considered as the most important link in neuroprotection, which has a pathogenetic justification. Metabolic correction in NDH can be divided into 3 groups: natural antioxidants, then endogenous oxidants coming from food, the 3rd group includes drugs of combination therapy and immunotherapy. Mexidol and selenoproteins have antihypoxic and antioxidant effects, which are realized at both the neuronal and vascular levels. Prospects for the development of effective metabolic drugs are associated with the restoration of mitochondrial dysfunction. Synchronization of the metabolic processes underlying the functioning of neuron structures will ensure neurogeneration, slow down neurodegenerative processes and increase life expectancy. FDA-approved drugs such as acetylcholinesterase inhibitors (donepezil, rivastigmine), as well as levodopa for the treatment of PD, which cross the blood-brain barrier and restore dopamine levels in the substantia nigra, only alleviate symptoms and slow the progression of diseases for several years. New therapeutic approaches aimed at neuroregeneration, i.e. structural and functional restoration of the damaged nervous system through immunomodulation, inhibition of the formation of protein aggregates, disaggregation of improperly folded proteins and induction of autophagy, give hope that the process of degeneration of affected neurons may slow down, and the recovery rate and life expectancy will increase. Due to the complex nature of NDT, a multi-purpose treatment approach is recommended, as it can have additional positive effects.

 окислительный стресс активные формы кислорода болезнь Паркинсона болезнь Альцгеймера аутоиммунные нарушения ранняя диагностика антиокидантная терапия oxidative stress reactive oxygen species antioxidants Parkinson’s disease Alzheimer’s disease autoimmune disorders early diagnosis stabilometry

Vorobyeva O. V. Oxidative stress associated with cerebrovascular dysfunction: possibilities of therapy, Farmateka, 5, 44 (2010). Vorobyeva O. V. Oxidative stress associated with cerebrovascular dysfunction: possibilities of therapy, Farmateka, 5, 44 (2010). Gomazkov O.A. Cellular and molecular principles of brain aging, Successes of modern biology, 132(2), 141 (2012). Gomazkov O.A. Cellular and molecular principles of brain aging, Successes of modern biology, 132(2), 141 (2012). Duma S. N. The possibilities of antioxidant therapy for asthenia and cognitive deficits in elderly patients with chronic cerebral ischemia, Therapeutic archive, 12, 100 (2013). Duma S. N. The possibilities of antioxidant therapy for asthenia and cognitive deficits in elderly patients with chronic cerebral ischemia, Therapeutic archive, 12, 100 (2013). Goncharova Z. A., Kolmakova T. S., Oksenjuk O. S., Morgul E. V., Gelpey M. A., Mutalieva Kh. M., Alpha-synuclein and oxidative stress enzymes as bio-markers of Parkinson's disease, Neurochemistry, 34, 2, 99 Goncharova Z. A., Kolmakova T. S., Oksenjuk O. S., Morgul E. V., Gelpey M. A., Mutalieva Kh. M., Alpha-synuclein and oxidative stress enzymes as bio-markers of Parkinson's disease, Neurochemistry, 34, 2, 99 Mikashinovich Z. I., Telesmanich N. R., Smirnova O. B., Chernogubova E. A. Biomarkers of oxidative stress and proteopathies in the diagnosis of neurodegenerative diseases, Molekular medicine, 2, 16 (2024) Mikashinovich Z. I., Telesmanich N. R., Smirnova O. B., Chernogubova E. A. Biomarkers of oxidative stress and proteopathies in the diagnosis of neurodegenerative diseases, Molekular medicine, 2, 16 (2024) Taylor J. P, Jr. Brown H. R., Don Cleveland W., Taylor J. P. Neurodegenerative diseases: G-quadruplex poses quadruple threat, Nature, 507, 175 (2014). Taylor J. P, Jr. Brown H. R., Don Cleveland W., Taylor J. P. Neurodegenerative diseases: G-quadruplex poses quadruple threat, Nature, 507, 175 (2014). Goncharova Z. A., Kolmakova T .S., Oxenyuk O. S., Morgul E. V., Gelpey M. A., Kalmykova Yu. A., Smirnova O. B., Mutalieva H. M. Multi-parametric assessment of biochemical markers of blood in Goncharova Z. A., Kolmakova T .S., Oxenyuk O. S., Morgul E. V., Gelpey M. A., Kalmykova Yu. A., Smirnova O. B., Mutalieva H. M. Multi-parametric assessment of biochemical markers of blood in Efimova M. Yu., Ivanova N. E., Alekseeva T. M., Ivanov A. Yu., Tereshin A. E., Makarov A. O., Reshetnik D.A. Molecular biomarkers of cognitive impairment in ischemic stroke. Medical Bulletin of the North Efimova M. Yu., Ivanova N. E., Alekseeva T. M., Ivanov A. Yu., Tereshin A. E., Makarov A. O., Reshetnik D.A. Molecular biomarkers of cognitive impairment in ischemic stroke. Medical Bulletin of the North Reed T. T. Lipid peroxidation and neurodegenerative disease, Free Radical.Biol. Med. 51, 1302 (2011) doi: 0.1016/j.freeradbiomed.2011.06.02732. Reed T. T. Lipid peroxidation and neurodegenerative disease, Free Radical.Biol. Med. 51, 1302 (2011) doi: 0.1016/j.freeradbiomed.2011.06.02732. Miller E., Markiewicz L., Kabzinski J., Odrobina D., Majsterek I., Miller E. et al. Potential of redox therapies in neurodegenerative disorders. Front Biosci (Elite Ed), 1, 9, (2), 214 (2017) doi: 10.2741/e797 Miller E., Markiewicz L., Kabzinski J., Odrobina D., Majsterek I., Miller E. et al. Potential of redox therapies in neurodegenerative disorders. Front Biosci (Elite Ed), 1, 9, (2), 214 (2017) doi: 10.2741/e797 Litvinenko I. V. Fundamental and methodological aspects of the study of progressive diseases of the central nervous system, Bulletin of the National Society for the Study of Parkinson's Disease Litvinenko I. V. Fundamental and methodological aspects of the study of progressive diseases of the central nervous system, Bulletin of the National Society for the Study of Parkinson's Disease Domanskyi A., Parlato R., Oxidative Stress in Neurodegenerative Diseases. Antioxidants, 11, 3, 504 (2022). https://doi.org/10.3390/antiox11030504 Domanskyi A., Parlato R., Oxidative Stress in Neurodegenerative Diseases. Antioxidants, 11, 3, 504 (2022). https://doi.org/10.3390/antiox11030504 Garcha-Snchez A., Miranda-Dhaz A. G., Cardona-Muuoz E. G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Garcha-Snchez A., Miranda-Dhaz A. G., Cardona-Muuoz E. G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Miller E., Walczak A., Saluk J., Ponczek M. B., Majsterek I. Oxidative modification of patient’s plasma proteins and its role in pathogenesis of multiple sclerosis, Clinical Biochemistr, 45, 1-2, 26 (2012). Miller E., Walczak A., Saluk J., Ponczek M. B., Majsterek I. Oxidative modification of patient’s plasma proteins and its role in pathogenesis of multiple sclerosis, Clinical Biochemistr, 45, 1-2, 26 (2012). Vilkov G. A., Smirnova O. B., Mezhova L. I. Correction of neuroimmune reactions by regulation of lipid peroxidation. Bulletin of Experimental Biology and Medicine. 116, 10, 364 (1993) (in Russian). Vilkov G. A., Smirnova O. B., Mezhova L. I. Correction of neuroimmune reactions by regulation of lipid peroxidation. Bulletin of Experimental Biology and Medicine. 116, 10, 364 (1993) (in Russian). Novikov V. E., Levchenkova O. S., Pozhilova Ye. V., Senerzhova E. V. The role of reactive oxygen species in cell physiology and pathology and their pharmacological regulation, Reviews on clinical Novikov V. E., Levchenkova O. S., Pozhilova Ye. V., Senerzhova E. V. The role of reactive oxygen species in cell physiology and pathology and their pharmacological regulation, Reviews on clinical Steinert, J. R., Chernova T., Forsythe I. D. Nitric oxide signaling in brain function, dysfunction, and dementia, Neuroscientist, 16, 435 (2010). doi: 10.1177/1073858410366481 Steinert, J. R., Chernova T., Forsythe I. D. Nitric oxide signaling in brain function, dysfunction, and dementia, Neuroscientist, 16, 435 (2010). doi: 10.1177/1073858410366481 Sidorova Y., Domanskyi A. Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients, Methods Protoc, 3, 4, 66 (2020) doi: 10.3390/mps3040066 Sidorova Y., Domanskyi A. Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients, Methods Protoc, 3, 4, 66 (2020) doi: 10.3390/mps3040066 Roberts R. A., Laskin D. L., Smith C. V., Robertson F. M., Allen E. M., Doorn J. A., Slikker W. Roberts R. A. Nitrative and oxidative stress in toxicology and disease, Toxicological sciences, 112, 1, 4 Roberts R. A., Laskin D. L., Smith C. V., Robertson F. M., Allen E. M., Doorn J. A., Slikker W. Roberts R. A. Nitrative and oxidative stress in toxicology and disease, Toxicological sciences, 112, 1, 4 Garcha-Spnchez A., Miranda-Dhaz A. G., Cardona-Mupoz E. G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Garcha-Spnchez A., Miranda-Dhaz A. G., Cardona-Mupoz E. G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Gomazkov O. A. Cellular and molecular principles of brain aging, Uspekhi sovremennoi biologii, 132, 2, 141 (2012) (In Russ.). Gomazkov O. A. Cellular and molecular principles of brain aging, Uspekhi sovremennoi biologii, 132, 2, 141 (2012) (In Russ.). Kirova Yu. I., Shakova F. M., Germanova E. L., Romanova G. A., Voronina T. A. The effect of Mexidol on cerebral mitochondriogenesis at a young age and during aging, S. S. Korsakov Journal of Neurology Kirova Yu. I., Shakova F. M., Germanova E. L., Romanova G. A., Voronina T. A. The effect of Mexidol on cerebral mitochondriogenesis at a young age and during aging, S. S. Korsakov Journal of Neurology Levin O. S., Bogolepova A. N. Cognitive rehabilitation of patients with neurodegenerative diseases, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 120, 5, 110 (2020). Levin O. S., Bogolepova A. N. Cognitive rehabilitation of patients with neurodegenerative diseases, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 120, 5, 110 (2020). Janssens J., Kleinberger G., Wils H., Van Broeckhoven C., The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration, Biochem Soc Trans, 39, 4, 954. Janssens J., Kleinberger G., Wils H., Van Broeckhoven C., The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration, Biochem Soc Trans, 39, 4, 954. Ivonina N. A., Petrov K. B. The use of neurotropic therapy in young patients with postcovid syndrome, S. S. Korsakov Journal of Neurology and Psychiatry, 122, 3, 126 (2022). Ivonina N. A., Petrov K. B. The use of neurotropic therapy in young patients with postcovid syndrome, S. S. Korsakov Journal of Neurology and Psychiatry, 122, 3, 126 (2022). Uddin M. S., Tewari D., Sharma G., Kabir M. T., Barreto G. E., Bin-Jumah M. N., Perveen A., Abdel-Daim M. M., Ashraf G. M. Molecular Mechanisms of ER Stress and UPR in the Pathogenesis Uddin M. S., Tewari D., Sharma G., Kabir M. T., Barreto G. E., Bin-Jumah M. N., Perveen A., Abdel-Daim M. M., Ashraf G. M. Molecular Mechanisms of ER Stress and UPR in the Pathogenesis Mondragyn-Rodrhguez S., Perry G., Zhu X., Boehm J. Amyloid beta and tau proteins as therapeutic targets for Alzheimer’s disease treatment: rethinking the current strategy, International Journal of Mondragyn-Rodrhguez S., Perry G., Zhu X., Boehm J. Amyloid beta and tau proteins as therapeutic targets for Alzheimer’s disease treatment: rethinking the current strategy, International Journal of Ellis G., Fang E., Maheshwari M., Roltsch E., Holcomb L., Zimmer D., Martinez D., Murray I. V., Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo, Journal of Alzheimer’s Disease, 22, 2, 593 Ellis G., Fang E., Maheshwari M., Roltsch E., Holcomb L., Zimmer D., Martinez D., Murray I. V., Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo, Journal of Alzheimer’s Disease, 22, 2, 593 Savelieff M. G., Lee S., Liu Y., Lim M. H. Untangling amyloid-β, tau, and metals in Alzheimer's disease, ACS Chemical Biology, 8, 856 (2013). Savelieff M. G., Lee S., Liu Y., Lim M. H. Untangling amyloid-β, tau, and metals in Alzheimer's disease, ACS Chemical Biology, 8, 856 (2013). Abramov A. Y., Berezhnov A. V., Fedotova E. I., Zinchenko V. P., Dolgacheva L. P. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders, Biochemical Society Transactions, Abramov A. Y., Berezhnov A. V., Fedotova E. I., Zinchenko V. P., Dolgacheva L. P. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders, Biochemical Society Transactions, Goncharova Z. A., Kolmakova T. S., Oksenyuk O. S., Morgul E. V., Gelpey M. A., Vlasova N. D., Smirnova O. B., Mutalieva H. M., Possible laboratory and instrumental markers of Parkinson’s disease Goncharova Z. A., Kolmakova T. S., Oksenyuk O. S., Morgul E. V., Gelpey M. A., Vlasova N. D., Smirnova O. B., Mutalieva H. M., Possible laboratory and instrumental markers of Parkinson’s disease Gros-Louis F., Gaspar C., Rouleau G. A. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta, 1762, 956 (2006). Gros-Louis F., Gaspar C., Rouleau G. A. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta, 1762, 956 (2006). Hardiman O., Al-Chalabi A., Chio A., Corr E. M., Logroscino G., Robberecht W., Shaw P. J. Simmons Z., van den Berg L. H. Amyotrophic lateral sclerosis., Nat. Rev. Dis. Prim., 3, 1707 (2017). Hardiman O., Al-Chalabi A., Chio A., Corr E. M., Logroscino G., Robberecht W., Shaw P. J. Simmons Z., van den Berg L. H. Amyotrophic lateral sclerosis., Nat. Rev. Dis. Prim., 3, 1707 (2017). Taylor J. P., Brown R. H. J., Cleveland D. W., Decoding ALS: From genes to mechanism, Nature, 539, 197 (2016). DOI: 10.1038/nature20413 Taylor J. P., Brown R. H. J., Cleveland D. W., Decoding ALS: From genes to mechanism, Nature, 539, 197 (2016). DOI: 10.1038/nature20413 Rakhit R., Crow J. P., Lepock J. R., Kondejewsk L. H., Cashman N. R., Chakrabartty A., Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial Rakhit R., Crow J. P., Lepock J. R., Kondejewsk L. H., Cashman N. R., Chakrabartty A., Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial Blasco H., Garcon G., Patin F., Veyrat-Durebex C., Boyer J., Devos D., Vourc’h P., Andres C. R., Corcia P. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study, Can. J. Neurol. Blasco H., Garcon G., Patin F., Veyrat-Durebex C., Boyer J., Devos D., Vourc’h P., Andres C. R., Corcia P. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study, Can. J. Neurol. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O’Regan J. P., Deng H. X., Mutations in Cu/Zn superoxide dismutase gene are associated with familial Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O’Regan J. P., Deng H. X., Mutations in Cu/Zn superoxide dismutase gene are associated with familial Zou Z., Zhou Z., Che C., Liu C., He R., Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis, J. Neurol. Neurosurg. Psychiatry., 88, 540, 193 (2017). Zou Z., Zhou Z., Che C., Liu C., He R., Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis, J. Neurol. Neurosurg. Psychiatry., 88, 540, 193 (2017). Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D. A., Trotti D., Pasinelli P., An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D. A., Trotti D., Pasinelli P., An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a Saccon R. A., Bunton-Stasyshyn R. K. A., Fisher E. M. C., Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis, Brain, 136, 2342 (2013). DOI: 10.1093/brain/awt097 Saccon R. A., Bunton-Stasyshyn R. K. A., Fisher E. M. C., Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis, Brain, 136, 2342 (2013). DOI: 10.1093/brain/awt097 Forsberg K., Andersen P. M., Marklund S. L, Brnnstrm T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis, Acta Neuropathol., 121, Forsberg K., Andersen P. M., Marklund S. L, Brnnstrm T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis, Acta Neuropathol., 121, Petrovic S., Medic D., Cvetkovic Z., Arsic A., Vucic V., Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A, Review of Human Studies. Antioxidants (Basel), 9, 11, 1128 Petrovic S., Medic D., Cvetkovic Z., Arsic A., Vucic V., Lipid Peroxidation and Antioxidant Supplementation in Neurodegenerative Diseases: A, Review of Human Studies. Antioxidants (Basel), 9, 11, 1128 Shchulkin A. V. A modern concept of antihypoxic and antioxidant effects of mexidol, S. S. Korsakov Journal of Neurology and Psychiatry, 118, 12-2, 87 (2018). (In Russ.) Shchulkin A. V. A modern concept of antihypoxic and antioxidant effects of mexidol, S. S. Korsakov Journal of Neurology and Psychiatry, 118, 12-2, 87 (2018). (In Russ.) Wang M., Liu Z., Sun W., Yuan Y., Jiao B., Zhang X., Shen L., Jiang H., Xia K., Tang B. Association Between Vitamins and Amyotrophic Lateral Sclerosis: A Center-Based Survey in Mainland China. Front. Neurol., Wang M., Liu Z., Sun W., Yuan Y., Jiao B., Zhang X., Shen L., Jiang H., Xia K., Tang B. Association Between Vitamins and Amyotrophic Lateral Sclerosis: A Center-Based Survey in Mainland China. Front. Neurol., Katasonov A. B., Anthocyanins for the prevention and treatment of neurodegenerative diseases, S. S. Korsakov Journal of Neurology and Psychiatry, 122, 4, 16 (2022) (In Russ.) Katasonov A. B., Anthocyanins for the prevention and treatment of neurodegenerative diseases, S. S. Korsakov Journal of Neurology and Psychiatry, 122, 4, 16 (2022) (In Russ.) Chukanova E. I., Chukanova A. S., Mamayeva Kh. I. The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia, S. S. Korsakov Journal of Neurology and Psychiatry, Chukanova E. I., Chukanova A. S., Mamayeva Kh. I. The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia, S. S. Korsakov Journal of Neurology and Psychiatry, Stakhovskaya L. V., Shamalov N. A., Khasanova D. R., Mel’nikova E. V., Agafiina A. S., Golikov K. V., Bogdanov U I., Yakupova A. A., Roshkovskaya L. V., Lukinykh L. V., Lokshtanova T. M., Stakhovskaya L. V., Shamalov N. A., Khasanova D. R., Mel’nikova E. V., Agafiina A. S., Golikov K. V., Bogdanov U I., Yakupova A. A., Roshkovskaya L. V., Lukinykh L. V., Lokshtanova T. M., Voronina T. A. Geroprotective effects of ethylmethylhydroxypyridine succinate in an experimental study. S. S. Korsakov Journal of Neurology and Psychiatry, 120, 4, 81 (2020) (In Russ.) Voronina T. A. Geroprotective effects of ethylmethylhydroxypyridine succinate in an experimental study. S. S. Korsakov Journal of Neurology and Psychiatry, 120, 4, 81 (2020) (In Russ.) Fedin A. I., Zakharov V. V., Tanashyan M. M., Chukanova E. I., Madzhidova E. N., Shchepankevich L. A., Ostroumova O. D. Results of an international multicenter, randomized, double-blind, placebo- Fedin A. I., Zakharov V. V., Tanashyan M. M., Chukanova E. I., Madzhidova E. N., Shchepankevich L. A., Ostroumova O. D. Results of an international multicenter, randomized, double-blind, placebo- Levin O. S., Diagnosis and treatment of cognitive impairment and dementia in clinical practice, MEDpress-inform, 2021 (ICBN:978-5-907632-94-3). Levin O. S., Diagnosis and treatment of cognitive impairment and dementia in clinical practice, MEDpress-inform, 2021 (ICBN:978-5-907632-94-3). Karpov S. M., Morozova M. Yu., Muravyov K. A., Vyshlova I. A., Kantemirova F. S. Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of Karpov S. M., Morozova M. Yu., Muravyov K. A., Vyshlova I. A., Kantemirova F. S. Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of Zakharov V. V., Tkacheva O. N., Mkhitaryan E. A., Fedin A. I. Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the Zakharov V. V., Tkacheva O. N., Mkhitaryan E. A., Fedin A. I. Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the Antipenko E. A., Shulyndin A. V., Belyakov K. M., Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia, S. S. Korsakov Journal of Neurology and Psychiatry, Antipenko E. A., Shulyndin A. V., Belyakov K. M., Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia, S. S. Korsakov Journal of Neurology and Psychiatry, Shchepankevich L. A., Nikolaev Yu. A., Taneeva E. V., Pervuninskaya M. A., Shchepankevich M. S., The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral Shchepankevich L. A., Nikolaev Yu. A., Taneeva E. V., Pervuninskaya M. A., Shchepankevich M. S., The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral Kirova Yu. I., Shakova F. M., Germanova E. L., Romanova G. A., Voronina T. A. The effect of Mexidol on cerebral mitochondriogenesis at a young age and aging, Zhurnal nevrologii i psikhiatrii im Kirova Yu. I., Shakova F. M., Germanova E. L., Romanova G. A., Voronina T. A. The effect of Mexidol on cerebral mitochondriogenesis at a young age and aging, Zhurnal nevrologii i psikhiatrii im Zhuravleva M. V., Shchukin I. A., Fidler M. S., Prokofiev A. B., Serebrova S. Yu., Vasyukova N. S., Demchenkova E. Yu., Arkhipov V. V. Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with Zhuravleva M. V., Shchukin I. A., Fidler M. S., Prokofiev A. B., Serebrova S. Yu., Vasyukova N. S., Demchenkova E. Yu., Arkhipov V. V. Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with Steinbrenner H., and Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervoussystem, Arch. Biochem. Biophys. 536, 152 (2013). Steinbrenner H., and Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervoussystem, Arch. Biochem. Biophys. 536, 152 (2013). Hanan S., El-Abhar Hanan M., Abd-El Gawad, Dalaal M., Abdallah and Hanan S., El-Abhar, Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10. Journal of Biological Sciences, 4, 8, Hanan S., El-Abhar Hanan M., Abd-El Gawad, Dalaal M., Abdallah and Hanan S., El-Abhar, Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10. Journal of Biological Sciences, 4, 8, Ghasemloo E., Mostafavi H., Hosseini M., Forouzandeh M., Eskandari M., and Mousavi S. S., Neuroprotective effects of coenzyme Q10 in Parkinson’s model via a novel Q10/miR-149-5p/MMPs Ghasemloo E., Mostafavi H., Hosseini M., Forouzandeh M., Eskandari M., and Mousavi S. S., Neuroprotective effects of coenzyme Q10 in Parkinson’s model via a novel Q10/miR-149-5p/MMPs Javier F., Jimnez J. Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review, Journal of Personalized Medicine, 12, 6, 975 (2022). doi: 10.3390/jpm12060975 Javier F., Jimnez J. Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review, Journal of Personalized Medicine, 12, 6, 975 (2022). doi: 10.3390/jpm12060975 Sandro Huenchuguala, Juan Segura-Aguilar, Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model, Biomolecules, 14, 6, Sandro Huenchuguala, Juan Segura-Aguilar, Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model, Biomolecules, 14, 6, Yubero-Serrano Elena M., Francisco M. Gutierrez-Mariscal, Antonio Garcia-Rios, Javier Delgado-Lista, Pablo Purez-Martinez, Antonio Camargo, Francisco Perez-Jimenez, Jose Lopez-Miranda, Coenzyme Q10 Yubero-Serrano Elena M., Francisco M. Gutierrez-Mariscal, Antonio Garcia-Rios, Javier Delgado-Lista, Pablo Purez-Martinez, Antonio Camargo, Francisco Perez-Jimenez, Jose Lopez-Miranda, Coenzyme Q10 Genova M.., Pich M. M., Biondi A., Bernacchia A., Falasca A., Bovina C., Formiggini G. Parenti, Castelli G., Lenaz G., Mitochondrial Production of Oxygen Radical Species and the Role of Coenzyme Q as an Genova M.., Pich M. M., Biondi A., Bernacchia A., Falasca A., Bovina C., Formiggini G. Parenti, Castelli G., Lenaz G., Mitochondrial Production of Oxygen Radical Species and the Role of Coenzyme Q as an Di Pierro D., Ciaccio C., Sbardella D., Tundo G. R., Bernardini R., Curatolo P., Cinzia G., Coletta M., Marini S. Effects of oral administration of common antioxidant supplements on the energy metabolism of red Di Pierro D., Ciaccio C., Sbardella D., Tundo G. R., Bernardini R., Curatolo P., Cinzia G., Coletta M., Marini S. Effects of oral administration of common antioxidant supplements on the energy metabolism of red